Coronavirus RSS Page 8

Filtered By:
Procedure: Ultrasound

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 1099 results found since Jan 2013.

Doppler ultrasound findings in symptomatic pregnant women diagnosed with COVID-19
J Obstet Gynaecol. 2022 Oct;42(7):2680-2683. doi: 10.1080/01443615.2022.2081799. Epub 2022 Jun 4.ABSTRACTThe primary aim of this study was to investigate the potential impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on maternal and foetal Doppler findings. Doppler ultrasound findings were compared in 40 pregnant women diagnosed with COVID-19 disease who required hospitalisation (group 1) and 30 healthy pregnant women (group 2). Maternal characteristics and birth histories were recorded. Body mass index, gestational week at birth, type of delivery, oligihydroamnios, pre-term birth (<37 we...
Source: Journal of Obstetrics and Gynaecology - January 3, 2023 Category: OBGYN Authors: Selami Erdem Mehmet Irfan Kulahcioglu Source Type: research

Diaphragm Muscle Weakness Might Explain Exertional Dyspnea Fifteen Months After Hospitalization for COVID-19
CONCLUSIONS: Diaphragm muscle weakness was present 15 months after hospitalization for COVID-19 even in patients who did not require mechanical ventilation, and this weakness was associated with dyspnea on exertion. The current study therefore identifies diaphragm muscle weakness as a correlate for persistent dyspnea in patients after COVID-19 in whom lung and cardiac function are normal. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).PMID:36596223 | DOI:10.1164/rccm.202206-1243OC
Source: Respiratory Care - January 3, 2023 Category: Respiratory Medicine Authors: Binaya Regmi Janina Friedrich Benedikt J örn Mehdi Senol Alberto Giannoni Matthias Boentert Ayham Daher Michael Dreher Jens Spiesshoefer Source Type: research

Diaphragm Muscle Weakness Might Explain Exertional Dyspnea Fifteen Months After Hospitalization for COVID-19
CONCLUSIONS: Diaphragm muscle weakness was present 15 months after hospitalization for COVID-19 even in patients who did not require mechanical ventilation, and this weakness was associated with dyspnea on exertion. The current study therefore identifies diaphragm muscle weakness as a correlate for persistent dyspnea in patients after COVID-19 in whom lung and cardiac function are normal. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).PMID:36596223 | DOI:10.1164/rccm.202206-1243OC
Source: American Journal of Respiratory and Critical Care Medicine - January 3, 2023 Category: Respiratory Medicine Authors: Binaya Regmi Janina Friedrich Benedikt J örn Mehdi Senol Alberto Giannoni Matthias Boentert Ayham Daher Michael Dreher Jens Spiesshoefer Source Type: research

Diaphragm Muscle Weakness Might Explain Exertional Dyspnea Fifteen Months After Hospitalization for COVID-19
CONCLUSIONS: Diaphragm muscle weakness was present 15 months after hospitalization for COVID-19 even in patients who did not require mechanical ventilation, and this weakness was associated with dyspnea on exertion. The current study therefore identifies diaphragm muscle weakness as a correlate for persistent dyspnea in patients after COVID-19 in whom lung and cardiac function are normal. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).PMID:36596223 | DOI:10.1164/rccm.202206-1243OC
Source: Am J Respir Crit Car... - January 3, 2023 Category: Intensive Care Authors: Binaya Regmi Janina Friedrich Benedikt J örn Mehdi Senol Alberto Giannoni Matthias Boentert Ayham Daher Michael Dreher Jens Spiesshoefer Source Type: research

Insights into the lung microenvironment after severe COVID-19
The SARS-CoV-2 is the betacoronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. Severe COVID-19 affects approximately 10-15% of patients and results in prolonged morbidity and mortality. Little is known about the immunophenotypic changes of the lung parenchyma driven by the viral infection in patients who die of severe COVID-19.Ultrasound-guided lung biopsies (LB) were collected (IRB approval#1561/21) within few hours from death in 15 severe COVID-19 patients between November 2020 and January 2021, in two patients who underwent lung transplantation after COVID-19 and in one patient who had surg...
Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Vaira, V., Storaci, A. M., Pitasi, M., Gentile, F., Blasi, F., Morlacchi, L. C., Pesenti, A., Grasselli, G., Tagliabue, P., Clerici, M. S., Malvestiti, F., Valenti, L., Aliberti, S., Gualtierotti, R., Ferrero, S., Nosotti, M., Bandera, A., Gori, A., Peyva Tags: 03.02 - Airway cell biology and immunopathology Source Type: research

Extensive right coronary artery thrombosis in a patient with COVID-19: A case report
CONCLUSION: This was the first report of RCA thrombosis in a patient with COVID-19. Dual antiplatelet/anticoagulation therapy was successful.PMID:36387805 | PMC:PMC9649551 | DOI:10.12998/wjcc.v10.i31.11508
Source: Atherosclerosis - November 17, 2022 Category: Cardiology Authors: Clarissa Campo Dall'Orto Rubens Pierry Ferreira Lopes Mariana Torres Cancela Ciria de Sales Padilha Gilvan Vilella Pinto Filho Marcos Raphael da Silva Source Type: research

Discussion on the causes of thrombolysis failure in a patient with STEMI: a case report
CONCLUSION: This was a case of failed STEMI thrombolysis in our hospital during the outbreak of COVID-19. This case indicates that doctors need to consider the cause of the disease when treating STEMI patients, especially patients without traditional cardiovascular risk factors. Moreover, CAG and intracoronary imaging examinations should be actively performed to identify the aetiology and improve the treatment success rate.PMID:36348268 | DOI:10.1186/s12872-022-02922-0
Source: Atherosclerosis - November 8, 2022 Category: Cardiology Authors: Lingzhi Qiu Jia Li Hua Yan Hui Guo Dan Song Xi Su Source Type: research

Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women
CONCLUSIONS: Using an extended 12-week interval between vaccine doses, antibody responses after two doses of mRNA COVID-19 vaccine were found to be lower in pregnant compared with non-pregnant women. Strong antibody responses were achieved after one dose in previously infected women, regardless of pregnancy status. Pregnant women reported fewer adverse events after both the first and second dose of vaccine. These findings should now be addressed in larger controlled studies. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound...
Source: The Ultrasound Review of Obstetrics and Gynecology - November 1, 2022 Category: Radiology Authors: H Blakeway Z Amin-Chowdhury S Prasad E Kalafat M Ismail F N Abdallah A Rezvani G Amirthalingam K Brown K Le Doare P T Heath S N Ladhani A Khalil Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20